Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
D000236:Adenoma / Q000175:diagnosis / Q000473:pathology; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000473:pathology; D000324:Adrenocorticotropic Hormone; D000450:Aldosterone / Q000097:blood*; D001794:Blood Pressure; D002784:Cholesterol; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000378:metabolism*; D007457:Iodine Radioisotopes; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood; D013148:Spironolactone / Q000627:therapeutic use*; D014316:Tritium
D007457:Iodine Radioisotopes; D014316:Tritium; D013148:Spironolactone; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone; D002784:Cholesterol; D012083:Renin; D011188:Potassium; D006854:Hydrocortisone